Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization), Disease , Product , End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations) & by Region - Trends & Forecast to 2018

NEW YORK, June 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization), Disease , Product , End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations) & by Region - Trends & Forecast to 2018

http://www.reportlinker.com/p02082019/Tissue-Diagnostics-Market-by-Technology-Immunohistochemistry-in-Situ-Hybridization-Disease--Product--End-Users-Hospitals-Pharmaceutical-companies-Research-Laboratories-Contract-Research-Organizations--by-Region----Trends--Forecast-to-2018.html

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018

Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. According to estimates by the International Agency for Research on Cancer (ICRA) and World Health Organization (WHO), 19.3 million new cancer cases are expected to be detected per year by 2025, up from the 14.1 million new cases reported in 2012. The rapidly increasing incidence of cancer is the most important growth driver for the tissue diagnostics market in the forecast period from 2013 to 2018. Advanced age is considered to be an important risk factor for cancer. People over 65 years of age account for close to 60% of all new cancer cases and close to 70% of all cancer deaths. The rapidly aging global population is expected to further drive the demand for tissue diagnostic products by 2018. Furthermore, increasing research funding for cancer has helped underline the importance of personalized medicine for cancer treatment. Tissue diagnostic-based companion diagnostics kits enable the identification of patients most likely to benefit from candidate drug products. The increasing use of personalized medicine is expected to further drive the market for tissue diagnostic products.

The report segments the global tissue diagnostics market by technology, disease, product, end user, and geography. Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market included in this report. The disease segments included in this report are breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases segments. The end-user segments of the tissue diagnostics market included in this report are hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users like reference laboratories. The report maps the technology, disease, product, and end-user profiles in each of the 20 regional and geographic segments. It provides a granular understanding of the current market size and provides a market forecast for 2018.

A combination of bottom-up and top-down approaches were used to calculate the market size and growth rates of the global tissue diagnostics market and its sub-segments. Secondary information was used to identify overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub-segments. It maps the market sizes and growth rates of each sub-segment and identifies the segments poised for rapid growth in each of the 20 geographic and regional segments. The report also includes the company profiles of market leaders. The profiles include financial performance, product portfolios, and market developments for each company. The report also provides a competitive landscape of these market leaders and identifies the key growth strategies in this market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios of top players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by technology, disease, and end users across geographies

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the tissue diagnostics market

• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the tissue diagnostics market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various tissue diagnostic products across geographies

• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the tissue diagnostics market

1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18

1.2 REPORT DESCRIPTION 18

1.3 MARKETS COVERED 20

1.4 STAKEHOLDERS 22

1.5 RESEARCH METHODOLOGY 23

1.5.1 SECONDARY RESEARCH 24

1.5.2 PRIMARY RESEARCH 25

1.5.2.1 Key data from primary sources 25

1.5.3 MARKET SIZE ESTIMATION METHODOLOGY 25

1.5.4 MARKET FORECAST 26

1.5.5 MARKET DATA VALIDATION & DATA TRIANGULATION 28

1.6 ASSUMPTIONS 29

2 EXECUTIVE SUMMARY 30

4.1 INTRODUCTION 42

4.2 MARKET SEGMENTATION 43

4.3 MARKET DYNAMICS 45

4.3.1 DRIVERS 46

4.3.1.1 Rising incidence of cancer is the primary driver for the tissue diagnostics market 46

4.3.1.2 Rapidly aging population will increase the disease burden of non-communicable diseases 46

4.3.1.3 Increased use of personalized medicine for cancer will drive the demand for tissue-based companion diagnostic tests 47

4.3.1.4 Growth in the IVD market will aid the growth of the tissue diagnostics market 47

4.3.2 RESTRAINTS 47

4.3.2.1 Lack of budget to restrict the growth of the market 47

4.3.2.2 Stringent regulatory framework acts as a major challenge for the tissue diagnostics market 48

4.4 MARKET SHARE ANALYSIS 49

4.5 PORTER'S ANALYSIS 52

4.5.1 THREAT FROM NEW ENTRANTS 52

4.5.2 THREAT FROM SUBSTITUTES 53

4.5.3 BARGAINING POWER OF BUYERS 53

4.5.4 BARGAINING POWER OF SUPPLIERS 53

4.5.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 54

5 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 55

5.1 INTRODUCTION 56

5.2 IMMUNOHISTOCHEMISTRY (IHC) 59

5.3 IN SITU HYBRIDIZATION (ISH) 62

5.4 DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT 64

5.5 SPECIAL STAINING 66

6 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE 68

6.1 INTRODUCTION 69

6.2 BREAST CANCER 73

6.3 GASTRIC CANCER 75

6.4 LYMPHOMA 77

6.5 PROSTATE CANCER 79

6.6 NON-SMALL CELL LUNG CARCINOMA (NSCLC) 81

6.7 OTHER DISEASES 83

7 GLOBAL TISSUE DIAGNOTICS MARKET, BY PRODUCT 85

7.1 INTRODUCTION 86

7.2 INSTRUMENTS 87

7.3 CONSUMABLES 89

8 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER 92

8.1 INTRODUCTION 93

8.2 HOSPITALS 96

8.3 PHARMACEUTICAL COMPANIES 98

8.4 RESEARCH LABORATORIES 99

8.5 CONTRACT RESEARCH ORGANIZATIONS (CRO) 101

8.6 OTHER END-USERS 103

9 GEOGRAPHIC ANALYSIS 104

9.1 INTRODUCTION 105

9.2 THE AMERICAS 108

9.2.1 U.S. 109

9.2.2 CANADA 114

9.2.3 MEXICO 120

9.2.4 CHILE 125

9.2.5 REST OF AMERICAS (ROA) 130

9.3 EUROPE 134

9.3.1 GERMANY 136

9.3.2 FRANCE 141

9.3.3 ITALY 146

9.3.4 SPAIN 151

9.3.5 U.K. 156

9.3.6 REST OF EUROPE (ROE) 161

9.4 BRIC 165

9.4.1 BRAZIL 166

9.4.2 CHINA 171

9.4.3 INDIA 175

9.4.4 RUSSIA 180

9.5 JAPAN 185

9.6 REST OF THE WORLD (ROW) 190

10 COMPETITIVE LANDSCAPE 194

10.1 INTRODUCTION 194

10.2 NEW PRODUCT LAUNCHES 195

10.3 AGREEMENTS, COLLABORATIONS, EXPANSIONS,

JOINT VENTURES AND PARTNERSHIPS 197

10.4 MERGERS AND ACQUISITIONS 199

10.5 OTHER DEVELOPMENTS 201

11 COMPANY PROFILES 203 (Business Overview, Products & Services, Key Strategy, & Recent Developments)*

11.1 ABBOTT LABORATORIES, INC. 203

11.2 AGILENT TECHNOLOGIES 206

11.3 BIOGENEX LABORATORIES 216

11.4 BIO SB. 219

11.5 CELL SIGNALLING TECHNOLOGY, INC. 222

11.6 DANAHER CORPORATION. 225

11.7 LIFE TECHNOLOGIES 233

11.8 ROCHE 237

11.9 SIGMA ALDRICH 243

11.10 THERMO FISHER SCIENTIFIC 247

*Details on Products & Services, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.APPENDIX 250

LIST OF TABLES

TABLE 1 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 57TABLE 2 GLOBAL IHC MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 61TABLE 3 GLOBAL ISH MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 63TABLE 4 GLOBAL DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 65TABLE 5 GLOBAL SPECIAL STAINING MARKET, BY GEOGRAPHY,2011–2018 ($MILLION) 67TABLE 6 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 71TABLE 7 GLOBAL BREAST CANCER TISSUE DIAGNOSTICS MARKET,BY GEOGRAPHY, 2011–2018 ($MILLION) 74TABLE 8 GLOBAL GASTRIC CANCER TISSUE DIAGNOSTICS MARKET,BY GEOGRAPHY, 2011–2018 ($MILLION) 76TABLE 9 GLOBAL LYMPHOMA TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 78TABLE 10 GLOBAL PROSTATE CANCER TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 80TABLE 11 GLOBAL NSCLC TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 82TABLE 12 GLOBAL OTHER DISEASES TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 84TABLE 13 GLOBAL TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 86TABLE 14 GLOBAL TISSUE DIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 88TABLE 15 GLOBAL TISSUE DIAGNOSTICS CONSUMABLES MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 90TABLE 16 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 94TABLE 17 GLOBAL HOSPITALS TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 97TABLE 18 GLOBAL PHARMACEUTICAL COMPANIES TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 98TABLE 19 GLOBAL ACADEMIC RESEARCH LABORATORIES TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 100TABLE 20 GLOBAL CRO TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 102TABLE 21 GLOBAL OTHER END-USERS TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 103TABLE 22 GLOBAL TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 107TABLE 23 THE AMERICAS: TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 109TABLE 24 U.S.: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 111TABLE 25 U.S.: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 112TABLE 26 U.S.: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 113TABLE 27 U.S.: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 114TABLE 28 CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 116TABLE 29 CANADA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 117TABLE 30 CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 118TABLE 31 CANADA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 119TABLE 32 MEXICO: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 121TABLE 33 MEXICO: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 122TABLE 34 MEXICO: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 123TABLE 35 MEXICO: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 124TABLE 36 CHILE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 126TABLE 37 CHILE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 127TABLE 38 CHILE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 128TABLE 39 CHILE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 129TABLE 40 ROA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 130TABLE 41 ROA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 131TABLE 42 ROA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 132TABLE 43 ROA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 133TABLE 44 EUROPE: TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 135TABLE 45 GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 137TABLE 46 GERMANY: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 138TABLE 47 GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 139TABLE 48 GERMANY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 140TABLE 49 FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 142TABLE 50 FRANCE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 143TABLE 51 FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 144TABLE 52 FRANCE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 145TABLE 53 ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 147TABLE 54 ITALY: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 148TABLE 55 ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 149TABLE 56 ITALY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 150TABLE 57 SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 152TABLE 58 SPAIN: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 153TABLE 59 SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 154TABLE 60 SPAIN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 155TABLE 61 U.K.: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 157TABLE 62 U.K.: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 158TABLE 63 U.K.: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 159TABLE 64 U.K.: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 160TABLE 65 ROE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 161TABLE 66 ROE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 162TABLE 67 ROE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 163TABLE 68 ROE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 164TABLE 69 BRIC: TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 165TABLE 70 BRAZIL: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 167TABLE 71 BRAZIL: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 168TABLE 72 BRAZIL: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 169TABLE 73 BRAZIL: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 170TABLE 74 CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 171TABLE 75 CHINA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 172TABLE 76 CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 173TABLE 77 CHINA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 174TABLE 78 INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 176TABLE 79 INDIA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 177TABLE 80 INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 178TABLE 81 INDIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 179TABLE 82 RUSSIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 181TABLE 83 RUSSIA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 182TABLE 84 RUSSIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 183TABLE 85 RUSSIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 184TABLE 86 JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 186TABLE 87 JAPAN: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 187TABLE 88 JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 188TABLE 89 JAPAN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 189TABLE 90 ROW: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 ($MILLION) 190TABLE 91 ROW: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 ($MILLION) 191TABLE 92 ROW: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 192TABLE 93 ROW: TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 ($MILLION) 193TABLE 94 NEW PRODUCT LAUNCH, 2010–2014 195TABLE 95 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010–2014 197TABLE 96 MERGERS AND ACQUISITIONS, 2010–2014 199TABLE 97 OTHER DEVELOPMENTS, 2010–2014 201

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 23FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 26FIGURE 3 MARKET FORECASTING MODEL 27FIGURE 4 DATA TRIANGULATION METHODOLOGY 28FIGURE 5 GLOBAL TISSUE DIAGNOSTICS MARKET BY TECHNOLOGY, 2013 VS. 2018 ($MILLION) 30FIGURE 6 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2013 VS. 2018 ($MILLION) 31FIGURE 7 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2013 VS. 2018 ($MILLION) 32FIGURE 8 GLOBAL TISSUE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2013 VS. 2018 ($MILLION) 33FIGURE 9 GLOBAL TISSUE DIAGNOSTICS MARKET, GEOGRAPHIC ANALYSIS, 2013 ($MILLION) 34FIGURE 10 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2013 35FIGURE 11 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2013 VS. 2018 35FIGURE 12 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2011–2018 (MARKET SIZES & GROWTH RATES) 36FIGURE 13 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013 37FIGURE 14 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013 VS. 2018 37FIGURE 15 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2011–2018 (MARKET SIZES & GROWTH RATES) 38FIGURE 16 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2013 39FIGURE 17 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2013 VS. 2018 39FIGURE 18 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2011–2018 (MARKET SIZES & GROWTH RATES) 40FIGURE 19 GLOBAL TISSUE DIAGNOSTICS MARKET SEGMENTATION 44FIGURE 20 GLOBAL TISSUE DIAGNOSTICS MARKET—DRIVERS & RESTRAINTS 45FIGURE 21 GLOBAL TISSUE DIAGNOSTICS DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 49FIGURE 22 PORTER'S FIVE FORCES ANALYSIS 52FIGURE 23 GLOBAL TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY 56FIGURE 24 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2013–2018 58FIGURE 25 GLOBAL TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY DISEASE 70FIGURE 26 GLOBAL TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2013–2018 72FIGURE 27 GLOBAL TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY END USERS 93FIGURE 28 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END USER, 2013–2018 95FIGURE 29 GLOBAL TISSUE DIAGNOSTICS MARKET, BY REGION, 2013 106FIGURE 30 KEY GROWTH STRATEGIES, TISSUE DIAGNOSTICS MARKET, 2010-2014 194FIGURE 31 ABBOTT LABORATORIES, INC. OVERVIEW 204FIGURE 32 AGILENT TECHNOLOGIES OVERVIEW 207FIGURE 33 DANAHER CORPORATION. OVERVIEW 226FIGURE 34 LIFE TECHNOLOGIES OVERVIEW 234FIGURE 35 ROCHE OVERVIEW 237FIGURE 36 SIGMA ALDRICH OVERVIEW 244FIGURE 37 THERMO FISHER SCIENTIFIC OVERVIEW 248To order this report: Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization), Disease , Product , End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations) & by Region - Trends & Forecast to 2018 http://www.reportlinker.com/p02082019/Tissue-Diagnostics-Market-by-Technology-Immunohistochemistry-in-Situ-Hybridization-Disease--Product--End-Users-Hospitals-Pharmaceutical-companies-Research-Laboratories-Contract-Research-Organizations--by-Region----Trends--Forecast-to-2018.html

__________________________
Contact Clare: [email protected]: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker